Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings
dc.contributor.author | Katayama, Hiroyuki | |
dc.contributor.author | Paczesny, Sophie | |
dc.contributor.author | Prentice, Ross | |
dc.contributor.author | Aragaki, Aaron | |
dc.contributor.author | Faca, Vitor M | |
dc.contributor.author | Pitteri, Sharon J | |
dc.contributor.author | Zhang, Qing | |
dc.contributor.author | Wang, Hong | |
dc.contributor.author | Silva, Melissa | |
dc.contributor.author | Kennedy, Jacob | |
dc.contributor.author | Rossouw, Jacques | |
dc.contributor.author | Jackson, Rebecca | |
dc.contributor.author | Hsia, Judith | |
dc.contributor.author | Chlebowski, Rowan | |
dc.contributor.author | Manson, JoAnn | |
dc.contributor.author | Hanash, Samir | |
dc.date.accessioned | 2015-08-07T17:49:31Z | |
dc.date.available | 2015-08-07T17:49:31Z | |
dc.date.issued | 2009-04-29 | |
dc.identifier.citation | Genome Medicine. 2009 Apr 29;1(4):47 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/112914 | en_US |
dc.description.abstract | Abstract Background The availability of serum collections from the Women's Health Initiative (WHI) conjugated equine estrogens (CEE) randomized controlled trial provides an opportunity to test the potential of in-depth quantitative proteomics to uncover changes in the serum proteome related to CEE and to assess their relevance to trial findings, including elevations in the risk of stroke and venous thromboembolism and a reduction in fractures. Methods Five independent large scale quantitative proteomics analyses were performed, each comparing a set of pooled serum samples collected from 10 subjects, 1 year following initiation of CEE at 0.625 mg/d, relative to their baseline pool. A subset of proteins that exhibited increased levels with CEE by quantitative proteomics was selected for validation studies. Results Of 611 proteins quantified based on differential stable isotope labeling, the levels of 116 (19%) were changed after 1 year of CEE (nominal P < 0.05), while 64 of these had estimated false discovery rates <0.05. Most of the changed proteins were not previously known to be affected by CEE and had relevance to processes that included coagulation, metabolism, osteogenesis, inflammation, and blood pressure maintenance. To validate quantitative proteomic data, 14 proteins were selected for ELISA. Findings for ten - IGF1, IGFBP4, IGFBP1, IGFBP2, F10, AHSG, GC, CP, MMP2, and PROZ - were confirmed in the initial set of 50 subjects and further validated in an independent set of 50 additional subjects who received CEE. Conclusions CEE affected a substantial fraction of the serum proteome, including proteins with relevance to findings from the WHI CEE trial related to cardiovascular disease and fracture. Clinical Trials Registration ClinicalTrials.gov identifier: NCT00000611 | |
dc.title | Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings | |
dc.type | Article | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/112914/1/13073_2009_Article_113.pdf | |
dc.identifier.doi | 10.1186/gm47 | en_US |
dc.language.rfc3066 | en | |
dc.rights.holder | Katayama et al.. | |
dc.date.updated | 2015-08-07T17:49:31Z | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.